share_log

EF Hutton Initiates Coverage On Ocean Biomedical With Buy Rating, Announces Price Target of $10

EF Hutton Initiates Coverage On Ocean Biomedical With Buy Rating, Announces Price Target of $10

EF Hutton 以买入评级开始报道海洋生物医学,宣布目标价为10美元
Benzinga ·  2023/03/13 07:13

EF Hutton analyst Michael King initiates coverage on Ocean Biomedical (NASDAQ:OCEA) with a Buy rating and announces Price Target of $10.

EF Hutton分析师迈克尔·金以买入评级开始对海洋生物医学(纳斯达克股票代码:OCEA)进行报道,并宣布目标价为10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发